Study by researchers at the University of Oklahoma Health Sciences Center demonstrates effectiveness of smartphone-based electrocardiogram (ECG) to detect atrial fibrillation among American Indians.

Chemo brain is an underrecognized but potentially debilitating side effect of cancer treatment. The phenomenon, formally known as chemotherapy-related cognitive impairment, can arise while patients are undergoing treatment, and it can persist months to years later.

Research results find comparable effectiveness between two medications and will guide further studies.

Amy Trueblood named Chief Nursing Officer for OU Health University of Oklahoma Medical Center.